Anthony Petrone
Stock Analyst at Mizuho Securities
(4.68)
# 828
Out of 5,125 analysts
690
Total ratings
54%
Success rate
9.3%
Average return
Main Sectors:
Stocks Rated by Anthony Petrone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SENS Senseonics Holdings | Reiterated: Buy | $18 → $20 | $10.03 | +99.40% | 7 | Nov 10, 2026 | |
| HAE Haemonetics | Reiterated: Buy | $140 → $165 | $122.36 | +34.85% | 73 | Nov 6, 2026 | |
| PLSE Pulse Biosciences | Reiterated: Buy | $55 → $65 | $55.12 | +17.92% | 8 | Nov 6, 2026 | |
| TFX Teleflex | Reiterated: Hold | $140 → $160 | $155.30 | +3.03% | 25 | Nov 6, 2026 | |
| TNDM Tandem Diabetes Care | Reiterated: Hold | $18 → $20 | $18.71 | +6.89% | 10 | Nov 6, 2026 | |
| ADMA ADMA Biologics | Reiterated: Buy | $17 → $18 | $12.67 | +42.07% | 35 | Nov 5, 2026 | |
| EW Edwards Lifesciences | Reiterated: Buy | $105 → $120 | $104.01 | +15.37% | 31 | Nov 5, 2026 | |
| LIVN LivaNova | Reiterated: Buy | $115 | $91.14 | +26.18% | 30 | Nov 5, 2026 | |
| RMD ResMed | Reiterated: Buy | $240 → $270 | $234.11 | +15.33% | 34 | Oct 30, 2026 | |
| AXGN Axogen | Reiterated: Buy | $58 → $65 | $50.89 | +27.73% | 5 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 → $50 | $44.70 | +11.86% | 27 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 → $90 | $83.65 | +7.59% | 22 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $185 → $225 | $236.19 | -4.74% | 29 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $7 | $3.37 | +107.72% | 21 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $415 → $400 | $450.04 | -11.12% | 20 | Oct 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 69.67 → CHF 65.57 | CHF 61.88 | +5.96% | 26 | Oct 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $95 → $100 | $79.92 | +25.13% | 15 | Oct 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $65 → $75 | $62.31 | +20.37% | 21 | Oct 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $115 → $109 | $101.62 | +7.26% | 38 | Oct 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $28 | $17.36 | +61.29% | 5 | Oct 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 → $75 | $63.57 | +17.98% | 40 | Sep 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $115 | $101.59 | +13.20% | 29 | Sep 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $12.69 | +73.36% | 2 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $3.50 | +328.57% | 1 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $105 | $67.23 | +56.18% | 31 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $22 → $27 | $23.87 | +13.11% | 31 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $7 | $4.23 | +65.48% | 4 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $12 → $5 | $6.43 | -22.24% | 7 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $125 → $115 | $110.46 | +4.11% | 20 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $80.54 | +24.16% | 1 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $155.35 | n/a | 1 | Jun 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $175 | $107.32 | n/a | 2 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $70 | $79.02 | n/a | 1 | Sep 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 | $0.80 | n/a | 3 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $45 | $73.83 | n/a | 7 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $86 | $14.53 | n/a | 1 | May 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $5.80 | n/a | 1 | Sep 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25 → $18 | $18.45 | n/a | 8 | Aug 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $0.000001 | n/a | 5 | Dec 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $6 | $3.19 | n/a | 7 | Aug 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $80 → $95 | - | n/a | 4 | Mar 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $93 | $197.00 | n/a | 1 | Aug 25, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $97 | $16.83 | n/a | 1 | Aug 2, 2016 |
Senseonics Holdings
Nov 10, 2026
Reiterated: Buy
Price Target: $18 → $20
Current: $10.03
Upside: +99.40%
Haemonetics
Nov 6, 2026
Reiterated: Buy
Price Target: $140 → $165
Current: $122.36
Upside: +34.85%
Pulse Biosciences
Nov 6, 2026
Reiterated: Buy
Price Target: $55 → $65
Current: $55.12
Upside: +17.92%
Teleflex
Nov 6, 2026
Reiterated: Hold
Price Target: $140 → $160
Current: $155.30
Upside: +3.03%
Tandem Diabetes Care
Nov 6, 2026
Reiterated: Hold
Price Target: $18 → $20
Current: $18.71
Upside: +6.89%
ADMA Biologics
Nov 5, 2026
Reiterated: Buy
Price Target: $17 → $18
Current: $12.67
Upside: +42.07%
Edwards Lifesciences
Nov 5, 2026
Reiterated: Buy
Price Target: $105 → $120
Current: $104.01
Upside: +15.37%
LivaNova
Nov 5, 2026
Reiterated: Buy
Price Target: $115
Current: $91.14
Upside: +26.18%
ResMed
Oct 30, 2026
Reiterated: Buy
Price Target: $240 → $270
Current: $234.11
Upside: +15.33%
Axogen
Oct 29, 2026
Reiterated: Buy
Price Target: $58 → $65
Current: $50.89
Upside: +27.73%
Oct 29, 2026
Reiterated: Buy
Price Target: $55 → $50
Current: $44.70
Upside: +11.86%
Oct 29, 2026
Reiterated: Buy
Price Target: $85 → $90
Current: $83.65
Upside: +7.59%
Oct 29, 2026
Reiterated: Buy
Price Target: $185 → $225
Current: $236.19
Upside: -4.74%
Oct 29, 2026
Reiterated: Buy
Price Target: $8 → $7
Current: $3.37
Upside: +107.72%
Oct 21, 2026
Reiterated: Hold
Price Target: $415 → $400
Current: $450.04
Upside: -11.12%
Oct 13, 2026
Reiterated: Buy
Price Target: CHF 69.67 → CHF 65.57
Current: CHF 61.88
Upside: +5.96%
Oct 13, 2026
Rated: Buy
Price Target: $95 → $100
Current: $79.92
Upside: +25.13%
Oct 13, 2026
Rated: Buy
Price Target: $65 → $75
Current: $62.31
Upside: +20.37%
Oct 13, 2026
Downgraded: Hold
Price Target: $115 → $109
Current: $101.62
Upside: +7.26%
Oct 8, 2026
Reiterated: Buy
Price Target: $26 → $28
Current: $17.36
Upside: +61.29%
Sep 11, 2026
Reiterated: Buy
Price Target: $85 → $75
Current: $63.57
Upside: +17.98%
Sep 2, 2026
Reiterated: Buy
Price Target: $100 → $115
Current: $101.59
Upside: +13.20%
Jul 28, 2026
Reiterated: Buy
Price Target: $22
Current: $12.69
Upside: +73.36%
Jul 17, 2026
Initiated Coverage: Buy
Price Target: $15
Current: $3.50
Upside: +328.57%
Jul 15, 2026
Reiterated: Buy
Price Target: $100 → $105
Current: $67.23
Upside: +56.18%
May 14, 2026
Reiterated: Hold
Price Target: $22 → $27
Current: $23.87
Upside: +13.11%
May 7, 2026
Reiterated: Buy
Price Target: $8 → $7
Current: $4.23
Upside: +65.48%
May 6, 2026
Reiterated: Hold
Price Target: $12 → $5
Current: $6.43
Upside: -22.24%
Apr 20, 2026
Reiterated: Hold
Price Target: $125 → $115
Current: $110.46
Upside: +4.11%
Apr 13, 2026
Reiterated: Buy
Price Target: $100
Current: $80.54
Upside: +24.16%
Jun 13, 2025
Reiterated: Buy
Price Target: $65
Current: $155.35
Upside: n/a
Nov 5, 2021
Reiterated: Buy
Price Target: $175
Current: $107.32
Upside: n/a
Sep 16, 2021
Rated: Buy
Price Target: $70
Current: $79.02
Upside: n/a
Aug 11, 2021
Rated: Buy
Price Target: $20
Current: $0.80
Upside: n/a
Aug 10, 2021
Rated: Buy
Price Target: $45
Current: $73.83
Upside: n/a
May 20, 2021
Rated: Buy
Price Target: $86
Current: $14.53
Upside: n/a
Sep 17, 2020
Initiated Coverage: Buy
Price Target: $15
Current: $5.80
Upside: n/a
Aug 13, 2020
Reiterated: Hold
Price Target: $25 → $18
Current: $18.45
Upside: n/a
Dec 3, 2019
Reiterated: Buy
Price Target: $7
Current: $0.000001
Upside: n/a
Aug 17, 2018
Reiterated: Buy
Price Target: $7 → $6
Current: $3.19
Upside: n/a
Mar 5, 2018
Reiterated: Hold
Price Target: $80 → $95
Current: -
Upside: n/a
Aug 25, 2017
Reiterated: Buy
Price Target: $93
Current: $197.00
Upside: n/a
Aug 2, 2016
Reiterated: Hold
Price Target: $97
Current: $16.83
Upside: n/a